News Prolight Diagnostics AB

Equities

PRLD

SE0003618230

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.155 ^SEK	-4.91%		+1.31%	-48.50%

Feb. 21	Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 21	Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prolight selects MDx CRO for the clinical performance studies for Psyros™	02:00am	AQ
Prolight Diagnostics AB (publ) publishes annual report for 2023	Apr. 30	AQ
BioStock: Prolight Diagnostics finalises cartridge design	Apr. 26	AQ
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)	Apr. 25	AQ
Emergers publishes updated analysis about Prolight Diagnostics	Apr. 25	AQ
Prolight finalizes commercial cartridge design	Apr. 24	AQ
Prolight writes down capitalized development costs for MicroFlex and delays publication of the annual report	Apr. 22	AQ
Prolight announces positive accounting adjustments for the full year 2023	Apr. 18	AQ
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)	Apr. 09	AQ
BioStock: Prolight Diagnostics' collaboration with G&H \| ITL propels development	Apr. 09	AQ
BioStock: Prolight's COO comments on partnership with FlexMedical Solutions	Apr. 04	AQ
Prolight Diagnostics selects FlexMedical Solutions as CMO partner	Mar. 27	AQ
BioStock: Prolight Diagnostics' CTO highlights the potential of the Psyros system	Feb. 27	AQ
Biostock publishes article about Prolight Diagnostics Q4 report	Feb. 23	AQ
Prolight Diagnostics CEO to BioStock: "We deliver on all goals"	Feb. 23	AQ
Prolight Diagnostics publishes year-end report 2023	Feb. 21	AQ
Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Emergers initiates equity research coverage of Prolight Diagnostics	Feb. 05	AQ
Equity Research \| PROLIGHT DIAGNOSTICS: Single molecule biomarker POC test upcoming	Feb. 05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Prolight Diagnostics AB

Equities

PRLD

SE0003618230

Summary

Filters